Search Results

2451 - 2475 of 75914
TitleWireDateTime
MarketWise Reports Net Revenue of $77.0 Million and Net Loss of $0.6 Million for First Quarter 2026; Q1 Billings Increase 15% YoY; Announced Quarterly Regular and Special Dividends totaling $0.45 per Class A share; Affirms FY 2026 Guidance of Billings of $300 Million and CFFO of $50 Million; Board Authorizes New $50M Share Buyback Program Globe Newswire 05/07 07:22
Entrada Therapeutics Reports First Quarter 2026 Financial Results Globe Newswire 05/07 07:10
TerrAscend Reports First Quarter 2026 Financial Results Globe Newswire 05/07 07:10
Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates Globe Newswire 05/07 07:05
GPGI Reports First Quarter 2026 Results Globe Newswire 05/07 07:05
Appian Announces First Quarter 2026 Financial Results Globe Newswire 05/07 07:05
Resolute Holdings Reports First Quarter 2026 Results Globe Newswire 05/07 07:05
Xometry Reports Record First Quarter 2026 Results Globe Newswire 05/07 07:05
Entrada Therapeutics Announces Positive Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study Globe Newswire 05/07 07:00
Commerce Announces First Quarter 2026 Financial Results Globe Newswire 05/07 07:00
Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement Globe Newswire 05/07 07:00
Chicago Atlantic Real Estate Finance Announces First Quarter 2026 Financial Results Globe Newswire 05/07 07:00
Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026 Globe Newswire 05/07 07:00
Codere Online Reports Financial Results for the First Quarter 2026 Globe Newswire 05/07 07:00
Foghorn Therapeutics Provides First Quarter 2026 Financial and Corporate Update Globe Newswire 05/07 07:00
OTC Markets Group Welcomes Belo Sun Mining Corp. to OTCQX Globe Newswire 05/07 07:00
Opus Genetics Completes Enrollment in Cohort 1 of Phase 1/2 OPGx-BEST1 Gene Therapy Study Globe Newswire 05/07 07:00
CareCloud Reports Q1 2026 Results Globe Newswire 05/07 07:00
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results Globe Newswire 05/07 07:00
Drill Program is Underway at VR’s New Boston Moly-Tungsten-Copper-Silver Porphyry Project in Nevada Globe Newswire 05/07 07:00
Climb Bio Reports First Quarter 2026 Financial Results and Provides Business Updates Globe Newswire 05/07 07:00
Akebia Therapeutics Reports First Quarter 2026 Financial Results and Commercial and Pipeline Highlights Globe Newswire 05/07 07:00
Peloton Announces Q3 FY2026 Financial Results Globe Newswire 05/07 07:00
USA Rare Earth Announces Date for Release of First Quarter 2026 Results and Conference Call Globe Newswire 05/07 07:00
Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 05/07 07:00
2451 - 2475 of 75914

News, Photo and Web Search